Antiproliferative effect of the serotonin receptor antagonist ondansetron in the acute lymphoblastic leukemia cell line REH

Authors

  • avier Prada Biomedical Research Center, Charité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Humboldt University of Berlin, Berlin, Germany; Department of Paediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany
  • Shabnam Shalapour Department of Paediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany
  • Madlen Pfau Department of Paediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany
  • Guenter Henze Department of Paediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany
  • Karl Seeger Department of Paediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany

DOI:

https://doi.org/10.3109/0284186X.2010.537691

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2011-05-01

How to Cite

Prada, avier, Shalapour, S., Pfau, M., Henze, G., & Seeger, K. (2011). Antiproliferative effect of the serotonin receptor antagonist ondansetron in the acute lymphoblastic leukemia cell line REH. Acta Oncologica, 50(4), 591–592. https://doi.org/10.3109/0284186X.2010.537691